| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
|
8,127 |
7,088 |
$375K |
| 99213 |
|
6,648 |
6,122 |
$227K |
| J9271 |
Inj pembrolizumab |
587 |
452 |
$184K |
| 96413 |
|
1,697 |
1,000 |
$140K |
| 99232 |
|
2,608 |
1,528 |
$81K |
| 96365 |
|
1,347 |
759 |
$80K |
| 85025 |
|
9,562 |
7,192 |
$46K |
| 99215 |
Prolong outpt/office vis |
180 |
148 |
$18K |
| J0897 |
Denosumab injection |
496 |
474 |
$17K |
| J1756 |
Iron sucrose injection |
3,559 |
1,384 |
$15K |
| 96375 |
|
565 |
313 |
$9K |
| 99233 |
Prolong inpt eval add15 m |
169 |
115 |
$8K |
| 99222 |
|
190 |
188 |
$7K |
| J1439 |
Inj ferric carboxymaltos 1mg |
316 |
206 |
$7K |
| J2469 |
Palonosetron hcl |
1,984 |
1,206 |
$5K |
| J0881 |
Darbepoetin alfa, non-esrd |
226 |
166 |
$3K |
| 99204 |
|
78 |
76 |
$3K |
| 94010 |
|
710 |
689 |
$2K |
| Q5106 |
Inj retacrit non-esrd use |
267 |
115 |
$2K |
| J0885 |
Epoetin alfa, non-esrd |
45 |
24 |
$2K |
| 96372 |
|
188 |
151 |
$1K |
| 96367 |
|
56 |
37 |
$986.31 |
| 99231 |
|
39 |
28 |
$746.24 |
| 94726 |
|
107 |
103 |
$605.25 |
| J1453 |
Fosaprepitant injection |
340 |
226 |
$587.52 |
| 94729 |
|
102 |
98 |
$465.72 |
| 96366 |
|
32 |
13 |
$417.66 |
| G2211 |
Complex e/m visit add on |
31 |
27 |
$390.18 |
| J1100 |
Dexamethasone sodium phos |
2,176 |
1,238 |
$385.33 |
| 96160 |
|
55 |
54 |
$92.67 |
| J1200 |
Diphenhydramine hcl injectio |
1,218 |
760 |
$51.87 |
| J1626 |
Granisetron hcl injection |
336 |
183 |
$0.00 |
| J3420 |
Vitamin b12 injection |
385 |
312 |
$0.00 |
| J0185 |
Inj., aprepitant, 1 mg |
205 |
137 |
$0.00 |
| 36415 |
|
26 |
24 |
$0.00 |
| J9190 |
Fluorouracil injection |
237 |
128 |
$0.00 |
| J7030 |
Normal saline solution infus |
93 |
40 |
$0.00 |
| J1437 |
Inj. fe derisomaltose 10 mg |
65 |
64 |
$0.00 |
| J0640 |
Leucovorin calcium injection |
79 |
45 |
$0.00 |
| J9201 |
In gemcitabine hcl nos 200mg |
27 |
12 |
$0.00 |